| abstract |
The invention relates to a pharmaceutical composition for treating and alleviating the symptoms of vulvitis and vulvovaginitis. The compositions according to the invention comprises 0.05-0.5 % by weight of folic acid, 0.25-2.5 % by weight of panthenol and/or 0.15-1.5 % by weight of allantoin, 0.75-7.5 % by weight of protein hydrolysate or casein hydrolysate, 3.0-15.0 % by weight of lactose or dextrose, 0.25-2.5 % by weight of lactic acid, 0.25-2.5 % by weight of magnesium sulfate and 0.75-7.5 % by weight of sodium chloride or ammonium chloride which are formulated in form of suppositories, ointments, solutions or sprays. |